Celsion Corporation to Present at White Mountain Capital Biotechnology Conference.Business Editors/Health/Medical Writers COLUMBIA, Md.--(BUSINESS WIRE)--April 21, 2004 Celsion Corporation (AMEX AMEX See: American Stock Exchange :CLN), a leading developer of therapies using heat or heat in combination with heat-activated drug or gene compounds, announced today that Anthony P. Deasey, the Company's Executive Vice President and Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. , will make a presentation at the 2nd Annual White Mountain Capital Biotechnology Conference. The event takes place Thursday, April 22nd at the Rihga Royal Hotel, located at 151 W. 54th Street in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The presentation is scheduled for 3:30 p.m. Mr. Deasey will provide an overview of Celsion's transition from a device to a biopharmaceutical-based company and of the Company's proprietary heat-activated liposome drug delivery platform. White Mountain Capital is a full-service investment firm serving individuals, corporations and institutions. In addition to its broker-dealer services, it provides clients with proprietary, independent research on select biotechnology companies. Forward-looking statements in this press release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by us and by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, and regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. About Celsion: Celsion Corporation, based in Columbia, Maryland, is a biotechnology company dedicated to the development and commercialization of treatment systems for cancer and other diseases using focused-heat energy, either administered alone or in combination with other therapeutic devices, heat-activated drugs or and heat activated genes. In January 2003, Celsion entered into a strategic alliance with Boston Scientific Corporation (NYSE NYSE See: New York Stock Exchange :BSX) in which Boston Scientific will initially distribute the Prolieve Thermodilatation system worldwide. Boston Scientific currently owns approximately 8% of Celsion's outstanding stock. Celsion has research, license or commercialization agreements with leading institutions such as the National Institute of Health, Duke University Medical Center, Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, , Harbor UCLA Medical Center, Montefiore Medical Center and Memorial Sloan-Kettering Cancer Center The Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets, with other locations in New in New York City, Roswell Park Cancer Institute The Roswell Park Cancer Institute is a cancer research and treatment center located in Buffalo, New York. Founded in 1898 by Dr. Roswell Park, it was the first dedicated medical facility for cancer treatment and research in the United States. in Buffalo, New York, and Duke University. For more information on Celsion, visit our website: www.celsion.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion